Antimicrobial-Resistant Pathogens: an Emerging Pediatric Threat

Advances in Pediatrics

Volumn 55, Issue 1, 2008, Pages 329-348

  Elliott, Sean P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

CHILD; COMMUNICABLE DISEASE; ECONOMICS; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; PENICILLIN RESISTANCE; PHYSIOLOGY; REVIEW; SOFT TISSUE INFECTION; SPORT; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; SOFT TISSUE INFECTIONS; SPORTS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 52049102453     PISSN: 00653101     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yapd.2008.07.004     Document Type: Review

References (115)

1. IDSA. Available at: (2007). http://www.idsociety.org/STAARAct.htm accessed December 1, 2007
2. Appelbaum P.C. Microbiology of antibiotic resistance in Staphylococcus aureus. Clin Infect Dis 45 (2007) S165-S170
3. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 339 (1998) 520-532
4. Boxerbaum B., Jacobs M.R., Cechner R.L., et al. Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. Pediatr Pulmonol 4 (1988) 159-163
5. Herold B.C., Immergluck L.C., Maranan M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279 (1998) 593-598
6. Hamoudi A.C., Palmer R.N., King T.L., et al. Nafcillin resistant Staphylococcus aureus: a possible community origin. Infect Control 4 (1983) 153-157
7. Dietrich D.W., Auld D.B., Mermel L.A., et al. Community-acquired methicillin-resistant Staphylococcus aureus in Southern New England children. Pediatrics 113 (2004) e347-e352
8. Jungk J., Como-Sabetti K., Stinchfield P., et al. Epidemiology of methicillin-resistant Staphylococcus aureus at a pediatric healthcare system, 1991-2003. Pediatr Infect Dis J 26 (2007) 339-344
9. Chen A.E., Goldstein M., Carroll K., et al. Evolving epidemiology of pediatric Staphylococcus aureus cutaneous infections in a Baltimore hospital. Pediatr Emerg Care 22 (2006) 717-723
10. Kaplan S.L., Hulten K.G., Gonzalez B.E., et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 40 (2005) 1785-1791
11. Avalos Mishaan A.M., Mason E.O., Martinez-Aguilar G., et al. Emergence of predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J 24 (2005) 201-206
12. Renner H., Munroe C.N., Durazo-Arvizu R., et al. Cost of provision of care of community-acquired MRSA patients in a Tertiary Care Pediatric Hospital (2007), ICAAC, Chicago
13. Noskin G.A., Rubin R.J., Schentag J., et al. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin Infect Dis 45 (2007) 1132-1140
14. Skiest D.J., Brown K., Cooper T.W., et al. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect 54 (2007) 427-434
15. Bratu S., Landman D., Gupta J., et al. A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York city. Ann Clin Microbiol Antimicrob 5 (2006) 29-33
16. Miller L.G., Perdreau-Remington F., Bayer A.S., et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 44 (2007) 471-482
17. Kuehnert M.J., Kruszon-Moran D., Hill H.A., et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 193 (2006) 172-179
18. Creech C.B., Kernodle D.S., Alsentzer A., et al. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 24 (2005) 617-621
19. Adcock P.M., Pastor P., Medley F., et al. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis 178 (1998) 577-580
20. Ellis M.W., Hospenthal D.R., Dooley D.P., et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 39 (2004) 971-979
21. Kazakova S.V., Hageman J.C., Matava M., et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352 (2005) 468-475
22. Daum R.S. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 357 (2007) 380-390
23. Clement S., Vaudaux P., Francois P., et al. Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis 192 (2005) 1023-1028
24. Carleton H.A., Diep B.A., Charlebois E.D., et al. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 190 (2004) 1730-1738
25. Shorr A.F. Epidemiology of staphylococcal resistance. Clin Infect Dis 45 (2007) S171-S176
26. Gonzalez B.E., Rueda A.M., Shelburne S.A., et al. Community-associated strains of methicillin-resistant Staphylococcus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol 27 (2006) 1051-1056
27. Maree C.L., Daum R.S., Boyle-Vavra S., et al. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis 13 (2007) 236-242
28. Berger-Bachi B., and Rohrer S. Factors influencing methicillin resistance in staphylococci. Arch Microbiol 178 (2002) 165-171
29. Siberry G.K., Tekle T., Carroll K., et al. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 37 (2003) 1257-1260
30. Lewis J.S., and Jorgensen J.H. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned?. Clin Infect Dis 40 (2005) 280-285
31. Diep B.A., Carleton H.A., Chang R.F., et al. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 193 (2006) 1495-1503
32. Baba T., Takeuchi F., Kuroda M., et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359 (2002) 1819-1827
33. Yamasaki O., Kaneko J., Morizane S., et al. The association between Staphylococcus aureus strains carrying panton-valentine leukocidin genes and the development of deep-seated follicular infection. Clin Infect Dis 40 (2005) 381-385
34. Voyich J.M., Otto M., Mathema B., et al. Is panton-valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?. J Infect Dis 194 (2006) 1761-1770
35. Bocchini C.E., Hulten K.G., Mason E.O., et al. Panton-valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 117 (2006) 433-440
36. Chi C.-Y., Wang S.-M., Lin H.-C., et al. A clinical and microbiological comparison of Staphylococcus aureus toxic shock and scalded skin syndromes in children. Clin Infect Dis 42 (2006) 181-185
37. Moran G.J., Krishnadasan A., Gorwitz R.J., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355 (2006) 666-674
38. Lee M.C., Rios A.M., Fonseca Aten M., et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 23 (2004) 123-127
39. Ruhe J.J., Smith N., Bradsher R.W., et al. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis 44 (2007) 777-784
40. Pannaraj P.S., Hulten K.G., Gonzalez B.E., et al. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 43 (2006) 953-960
41. Miller L.G., Perdreau-Remington F., Rieg G., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352 (2005) 1445-1453
42. Gonzalez B.E., Teruya J., Mahoney D.H., et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics 117 (2006) 1673-1679
43. Dohin B., Gillet Y., Kohler R., et al. Pediatric bone and joint infections caused by panton-valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J 26 (2007) 1042-1048
44. Gonzalez B.E., Hulten K.G., Dishop M.K., et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis 41 (2005) 583-590
45. Mongkolrattanothai K., Boyle S., Kahana M.D., et al. Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis 37 (2003) 1050-1058
46. Bradley S.F. Staphylococcus aureus pneumonia: emergence of MRSA in the community. Semin Respir Crit Care Med 26 (2005) 643-649
47. Francis J.S., Doherty M.C., Lopatin U., et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the panton-valentine leukocidin genes. Clin Infect Dis 40 (2005) 100-107
48. Shulman S.T., and Ayoub E.M. Severe staphylococcal sepsis in adolescents. Pediatrics 58 (1976) 59-66
49. Adem P.V., Montgomery C.P., Husain A.N., et al. Staphylococcus aureus sepsis and the waterhouse-friderichsen syndrome in children. N Engl J Med 353 (2005) 1245-1251
50. Castaldo E.T., and Yang E.Y. Severe sepsis attributable to community-associated methicillin-resistant Staphylococcus aureus: an emerging problem. Am Surg 73 (2007) 684-687
51. Creech C.B., Johnson B.G., Bartilson R.E., et al. Increasing use of extracorporeal life support in methicillin-resistant Staphylococcus aureus sepsis in children. Pediatr Crit Care Med 8 (2007) 231-235
52. Cosgrove S.E., Sakoulas G., Perencevich E.N., et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36 (2003) 53-59
53. Begier E.M., Frenette K., Barrett N.L., et al. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis 39 (2004) 1446-1453
54. CDC. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR 52 (2003) 793-795
55. Stacey A.R., Endersby K.E., Chan P.C., et al. An outbreak of methicillin-resistant Staphylococcus aureus infection in a rugby football team. Br J Sports Med 32 (1998) 153-154
56. Huletsky A., Giroux R., Rossbach V., et al. New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J Clin Microbiol 42 (2004) 1875-1884
57. Rajan L., Smyth E., and Humphreys H. Screening for MRSA in ICU patients. How does PCR compare with culture. J Infect 55 (2007) 353-357
58. Fang H., and Hedin G. Rapid screening and identification of methicillin-resistant Staphylococcus aureus from clinical samples by selective-broth and real-time PCR assay. J Clin Microbiol 41 (2003) 2894-2899
59. Huang S.S., Yokoe D.S., Hinrichsen V.L., et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus Bacteremia. Clin Infect Dis 43 (2006) 971-978
60. Huang S.S., Rifas-Shiman S.L., Warren D.K., et al. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis 195 (2007) 330-338
61. Hidron A.I., Kourbatova E.V., Halvosa J.S., et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 41 (2005) 159-166
62. Jones J.C., Rogers T.J., Brookmeyer P., et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 45 (2007) 541-547
63. Gentry D.R., Rittenhouse S.F., McCloskey L., et al. Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin. Antimicrob Agents Chemother 51 (2007) 2048-2052
64. Szumowski J.D., Cohen D.E., Kanaya F., et al. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother 51 (2007) 423-428
65. Martinez-Aguilar G., Hammerman W.A., Mason E.O., et al. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 22 (2003) 593-598
66. Szczesiul J.M., Shermock K.M., Idrees Murtaza U., et al. No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infections. Pediatr Infect Dis J 26 (2007) 852-854
67. Ruhe J.J., and Menon A. Tetracyclines as an oral treatment option for patients with community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections. Antimicrob Agents Chemother 51 (2007) 3298-3303
68. Iyer S., and Jones D.H. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak. J Am Acad Dermatol 50 (2004) 854-858
69. Stevens D.L., Ma Y., Salmi D.B., et al. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 195 (2007) 202-211
70. Segers P., Speekenbrink R.G.H., Ubbink D.T., et al. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate; a randomized controlled trial. JAMA 296 (2006) 2460-2466
71. Simor A.E., Phillips E., McGeer A., et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 44 (2007) 178-185
72. Singh N., Patel K.M., Leger M.-M., et al. Risk of resistant infections with Enterobacteriaceae in hospitalized neonates. Pediatr Infect Dis J 21 (2002) 1029-1033
73. Fridkin S.K., Steward C.D., and Edwards J.R. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phases 2. Clin Infect Dis 29 (1999) 245-252
74. Bizzarro J.J., and Gallagher P.G. Antibiotic-resistant organisms in the neonatal intensive care unit. Semin Perinatol 31 (2007) 26-32
75. Toltzis P., Dul M.J., and Hoyen C. Molecular epidemiology of antibiotic-resistant gram-negative bacilli in a neonatal intensive care unit during a nonoutbreak period. Pediatrics 108 (2001) 1143-1148
76. Baltimore R.S., Huie S.M., and Meek J.I. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 108 (2001) 1094-1098
77. Cordero L., Rau R., and Taylor D. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit. Am J Infect Control 32 (2004) 189-195
78. Joseph T.A., Pyati S.P., and Jacobs N. Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin. Arch Pediatr Adolesc Med 152 (1998) 35-40
79. Cosgrove S.E. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42 (2006) S82-S89
80. Stoll B.J., Hansen N.I., Higgins R.D., et al. Very low birth weight preterm infants with early onset neonatal sepsis. Pediatr Infect Dis J 24 (2005) 635-639
81. Mammina C., Di Carlo P., Cipolla D., et al. Surveillance of multi-drug resistant gram-negative bacilli in a neonatal intensive care unit: prominent role of cross transmission. Am J Infect Control 35 (2007) 222-230
82. Correa A.G., et al. Acinetobacter. In: Feigin R.D., Cherry J.D., and Demmler G.J. (Eds). Textbook of pediatric infectious diseases vol. 1 (2004), Saunders, Philadelphia 1544-1548
83. Hujer K.M., Hujer A.M., Hulten E.A., et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50 (2006) 4114-4123
84. Huang Y.-C., Su L.-H., Wu T.-L., et al. Outbreak of Acinetobacter baumannii bacteremia in a neonatal intensive care unit: clinical implications and genotyping analysis. Pediatr Infect Dis J 21 (2002) 1105-1109
85. von Dolinger de Brito D., Oliveira E.J., Abdallah V.O., et al. An outbreak of Acinetobacter baumannii septicemia in a neonatal intensive care unit of a university hospital in Brazil. Braz J Infect Dis 9 (2005) 301-309
86. Chan P.C., Huang L.M., Lin H.C., et al. Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 28 (2007) 423-429
87. Segal S.C., Zaoutis T.E., Kagen J., et al. Epidemiology of and risk factors for Acinetobacter species bloodstream infection in children. Pediatr Infect Dis J 26 (2007) 920-926
88. Sunenshine R.H., Wright M.-O., Maragakis L.L., et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 13 (2007) 97-103
89. Albrecht M.A., Griffith M.E., Murray C.K., et al. Impact of Acinetobacter infection on the mortality of burn patients. J Am Coll Surg 203 (2006) 546-550
90. Trottier V., Gonzalez Segura P., Namias N., et al. Outcomes of Acinetobacter baumannii infection in critically ill burned patients. J Burn Care Res 28 (2007) 248-254
91. Lee K., Yum J.H., Yong D., et al. Novel acquired metallo-B-lactamase gene, blaSIN-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 49 (2005) 4485-4491
92. Gales A.C., Jones R.N., and Forward K.R. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997-1999). Clin Infect Dis 32 Suppl 2 (2001) 104-113
93. Li J., Nation R.L., Owen R.J., et al. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains. Clin Infect Dis 45 (2007) 594-598
94. Holloway K.P., Rouphael N.G., Wells J.B., et al. Polymixin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit. Ann Pharmacother 40 (2006) 1939-1945
95. World Health Organization. Available at: http://www.who.org; accessed December 1, 2007.
96. CDC. Preventing pneumococcal disease among infants and young children: recommendations of the advisory committee on immunization practices. MMWR 49 (2000) 1-35
97. Black S., Shinefield H., Fireman B., et al. Efficacy, safety, and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19 (2000) 187-195
98. Steenhoff A.P., Shah S.S., Ratner A.J., et al. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clin Infect Dis 42 (2006) 907-914
99. Eskola J., Kilpi T., and Palmu A. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344 (2001) 403-409
100. Dagan R., Melamed R., and Muallem M. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 174 (1996) 1271-1278
101. O'Brien K.L., Millar E.V., Zell E.R., et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 196 (2007) 1211-1220
102. Moore M., Hyde T.B., and Hennessey T.W. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae isolates. J Infect Dis 190 (2004) 2031-2038
103. Finkelstein J.A., Huang S.S., Daniel J., et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics 112 (2003) 862-869
104. Farrell D.J., Klugman K.P., and Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J 26 (2007) 123-128
105. Whitney C.G., Farley M.M., and Hadler J.L. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348 (2003) 1737-1746
106. Pelton S.I., Huot H., Finkelstein J.A., et al. Emergence of 19a as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 26 (2007) 468-472
107. Pai R., Moore M.R., Pilishvili T., et al. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19a from children in the United States. J Infect Dis 192 (2005) 1988-1995
108. Hicks L.A., Harrison L.H., Flannery B., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 196 (2007) 1346-1354
109. Greenberg D., Dagan R., Muallem M., et al. Antibiotic-resistant invasive pediatric Streptococcus pneumoniae clones in Israel. J Clin Microbiol 41 (2003) 5541-5545
110. Yao K., Shen X., Yu S., et al. Antimicrobial resistance and serotypes of nasopharyngeal strains of Streptococcus pneumoniae in Chinese children with acute respiratory infections. J Int Med Res 35 (2007) 253-267
111. Brandileone M.-C.C., Casagrande S.T., Guerra M.-L.L.S., et al. Increase in numbers of B-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact of conjugate vaccine coverage. J Med Microbiol 55 (2006) 567-574
112. Nunes S., Sa-Leao R., Carrico J., et al. Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool-age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance. J Clin Microbiol 43 (2005) 1285-1293
113. Katz A., Leibovitz E., Timchenko V.N., et al. Antibiotic susceptibility, serotype distribution and vaccine coverage of nasopharyngeal and oropharyngeal Streptococcus pneumoniae in a day-care centre in St. Petersburg, Russia. Scand J Infect Dis 39 (2007) 293-298
114. Lauderdale T.-L., Wagener M.M., Lin H.M., et al. Serotype and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from Taiwanese children: comparison of nasopharyngeal and clinical isolates. Diagn Microbiol Infect Dis 56 (2006) 421-426
115. Byington C.L., Samore M.H., Stoddard G.J., et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 41 (2005) 21-29